CSF3 and Miyoshi myopathy: This comparative effectiveness study describes the use of BIO/PEG in patients with MM receiving HDM and undergoing ASCT to assess the relative benefits of BIO/PEG in comparison with historic controls (i.e., BIO/G-CSF and PEG).